Provided by Tiger Trade Technology Pte. Ltd.

Lantern Pharma Inc.

0.8599
-0.0501-5.51%
Volume:95.77K
Turnover:83.34K
Market Cap:12.84M
PE:-0.53
High:0.9000
Open:0.8885
Low:0.8300
Close:0.9100
52wk High:4.70
52wk Low:0.8300
Shares:14.94M
Float Shares:12.00M
Volume Ratio:0.90
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6362
EPS(LYR):-1.5709
ROE:-400.92%
ROA:-74.29%
PB:-3.99
PE(LYR):-0.55

Loading ...

Mar 10, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 11, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jan 08, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 08, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jan 06, 2021

Major Issues Report

8-K - Current report
Oct 29, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2020

Major Issues Report

8-K - Current report
Aug 21, 2020

Major Issues Report

8-K - Current report
Jul 30, 2020

Major Issues Report

8-K - Current report
Jul 30, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 16, 2020

Major Issues Report

8-K - Current report
Jun 23, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 23, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 19, 2020

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 17, 2020

Major Issues Report

8-K - Current report